Myelodysplastic Syndromes (MDS) and Elderly Leukemia
At KU Medical Center, medical professionals are pioneering the development of treatments for patients with Myelodysplastic Syndromes (MDS) and Elderly Leukemia.
Our physician faculty are part of Cancer Site Specific Teams working closely to develop comprehensive quality cancer care at KU Cancer Center, recognized as an MDS Center of Excellence. Visit KU Cancer Center to learn more about MDS and elderly leukemia.
There are many clinical trials underway at The University of Kansas Cancer Center, studying treatments for leukemias. Visit KU Cancer Center to explore clinical trials or reach out for more information.
Contact our Clinical Trial Nurse Navigator:
- Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome (MDS)
- PI: Abdulraheem Yacoub, MD
- Visit NCT# 01772420 to learn national information about this trial.
MDS/Elderly Leukemia Trials:
- Leukemia, Other
- Leukemia, Not Specified
- Myeloid Leukemia
- Monocytic Leukemia
- Clinical Trial Main Page
Visit KU Cancer Center for information about support groups and other resources for patients and families. Visit Gilda's Club (support for all cancers and stages) or Cancer Action (for programs and services of persons with cancer, their family and friends).